Seeking AlphaTue, 12 May 2026 21:30:48 GMTRecursion Pharmaceuticals, Inc. (RXRX) Presents at Bank of America Global Healthcare Conference 2026 TranscriptRXRX-3.17%
BenzingaThu, 07 May 2026 17:04:59 GMTRecursion Eyes Breakthrough With REC-4881 Drug For Rare Genetic Condition, But Shares Pull BackRXRX-3.17%
Zacks Investment ResearchThu, 07 May 2026 16:30:42 GMTRXRX Q1 Loss Narrower Than Expected, Revenues Decline Y/YRXRX-3.17%
Seeking AlphaWed, 06 May 2026 23:51:15 GMTRecursion Pharmaceuticals, Inc. (RXRX) Q1 2026 Earnings Call TranscriptRXRX-3.17%
Zacks Investment ResearchWed, 06 May 2026 12:45:40 GMTRecursion Pharmaceuticals (RXRX) Reports Q1 Loss, Lags Revenue EstimatesRXRX-3.17%
Zacks Investment ResearchFri, 01 May 2026 22:45:22 GMTRecursion Pharmaceuticals (RXRX) Stock Dips While Market Gains: Key FactsRXRX-3.17%
Seeking AlphaTue, 28 Apr 2026 00:16:55 GMTRecursion Pharmaceuticals May Be Losing Ground To Its PeersRXRX-3.17%
Zacks Investment ResearchThu, 23 Apr 2026 22:51:24 GMTHere's Why Recursion Pharmaceuticals (RXRX) Fell More Than Broader MarketRXRX-3.17%
Seeking AlphaFri, 17 Apr 2026 05:41:47 GMTRecursion Pharmaceuticals, Inc. (RXRX) Presents at 25th Annual Needham Virtual Healthcare Conference TranscriptRXRX-3.17%
Zacks Investment ResearchThu, 16 Apr 2026 22:51:14 GMTRecursion Pharmaceuticals (RXRX) Stock Drops Despite Market Gains: Important Facts to NoteRXRX-3.17%
Zacks Investment ResearchThu, 09 Apr 2026 22:50:48 GMTRecursion Pharmaceuticals (RXRX) Stock Declines While Market Improves: Some Information for InvestorsRXRX-3.17%
Zacks Investment ResearchThu, 02 Apr 2026 22:50:29 GMTRecursion Pharmaceuticals (RXRX) Beats Stock Market Upswing: What Investors Need to KnowRXRX-3.17%
Zacks Investment ResearchFri, 27 Mar 2026 22:51:20 GMTHere's Why Recursion Pharmaceuticals (RXRX) Fell More Than Broader MarketRXRX-3.17%
Zacks Investment ResearchFri, 27 Mar 2026 16:31:18 GMTRecursion Pharmaceuticals (RXRX) Down 16.5% Since Last Earnings Report: Can It Rebound?RXRX-3.17%
Seeking AlphaSat, 21 Mar 2026 00:02:16 GMTRecursion Pharmaceuticals, Inc. (RXRX) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum TranscriptRXRX-3.17%
Zacks Investment ResearchThu, 19 Mar 2026 22:50:53 GMTRecursion Pharmaceuticals (RXRX) Advances While Market Declines: Some Information for InvestorsRXRX-3.17%
Zacks Investment ResearchTue, 10 Mar 2026 22:45:25 GMTRecursion Pharmaceuticals (RXRX) Sees a More Significant Dip Than Broader Market: Some Facts to KnowRXRX-3.17%
Seeking AlphaFri, 06 Mar 2026 17:35:54 GMTRecursion Pharmaceuticals, Inc. (RXRX) Presents at TD Cowen 46th Annual Health Care Conference TranscriptRXRX-3.17%
Zacks Investment ResearchWed, 25 Feb 2026 18:20:39 GMTRecursion Pharmaceuticals (RXRX) Reports Q4 Loss, Beats Revenue EstimatesRXRX-3.17%